Sodium-Glucose Cotransporter-2 Inhibitor for Renal Function Preservation in Patients with Type 2 Diabetes Mellitus: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement
Tae Jung Oh (Oh TJ), Ju-Young Moon (Moon JY), Kyu Yeon Hur (Hur KY), Seung Hyun Ko (Ko SH), Hyun Jung Kim (Kim HJ), Taehee Kim (Kim T), Dong Won Lee (Lee DW), Min Kyong Moon (Moon MK), , ,
Diabetes Metab J. 2020;44(4):489-497.   Published online 2020 Aug 21     DOI: https://doi.org/10.4093/dmj.2020.0172
Citations to this article as recorded by Crossref logo
Renoprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors: Focusing on Renal Hemodynamics
Nam Hoon Kim, Nan Hee Kim
Diabetes & Metabolism Journal.2022; 46(4): 543.     CrossRef
Real-World Prescription Patterns and Barriers Related to the Use of Sodium-Glucose Cotransporter 2 Inhibitors among Korean Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease
Jong Ha Baek, Ye Seul Yang, Seung-Hyun Ko, Kyung Do Han, Jae Hyeon Kim, Min Kyong Moon, Jong Suk Park, Byung-Wan Lee, Tae Jung Oh, Suk Chon, Jong Han Choi, Kyu Yeon Hur
Diabetes & Metabolism Journal.2022; 46(5): 701.     CrossRef